Matches in Wikidata for { <http://www.wikidata.org/entity/Q91608358> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q91608358 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91608358 description "scientific article published on 01 July 2019" @default.
- Q91608358 description "wetenschappelijk artikel" @default.
- Q91608358 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q91608358 name "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 name "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 type Item @default.
- Q91608358 label "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 label "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 prefLabel "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 prefLabel "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 P1433 Q91608358-D9698807-D3F9-419F-B9D9-861E0AE7D6DF @default.
- Q91608358 P1476 Q91608358-1486BDD2-A033-42DB-83FD-771A1750E492 @default.
- Q91608358 P2093 Q91608358-19DBA24C-C64F-416C-9C51-20B81E755E6D @default.
- Q91608358 P2093 Q91608358-1BD62641-13B2-447C-986B-DD736C86720C @default.
- Q91608358 P2093 Q91608358-1D3A1EF3-A363-469B-B44C-E350BE066311 @default.
- Q91608358 P2093 Q91608358-4C3501C1-0174-4F26-B3A6-D5C3B7FA2926 @default.
- Q91608358 P2093 Q91608358-772CF0C9-7581-44A6-B3F1-984ABCB610AC @default.
- Q91608358 P2093 Q91608358-B848F303-A1CE-4A33-8F30-D2DB03D98236 @default.
- Q91608358 P2093 Q91608358-CBDCC2AB-508E-4CAD-B84A-BA210CA9C799 @default.
- Q91608358 P2093 Q91608358-D9905AB0-6B21-4D9D-A3D8-E2AC291BEC00 @default.
- Q91608358 P304 Q91608358-944D7DC0-17EC-41DA-BCAE-4153C213D388 @default.
- Q91608358 P31 Q91608358-27BF9B81-BEDB-4A45-9C4C-5043B83C59DD @default.
- Q91608358 P356 Q91608358-E7F32A5F-469A-4BFA-A043-8B71B77E7298 @default.
- Q91608358 P478 Q91608358-1C897348-1B84-4B43-91EC-45A9E6F2AED0 @default.
- Q91608358 P577 Q91608358-6CA80C08-6927-4318-B517-24D8DDF4D48C @default.
- Q91608358 P698 Q91608358-1923E0EF-86E8-487D-BB6D-2EDCD69290B9 @default.
- Q91608358 P921 Q91608358-619B0814-5DD2-4D03-BC08-4C5C9052D2E7 @default.
- Q91608358 P921 Q91608358-7EC51191-7754-4ED9-96D7-A729DBB4AB6F @default.
- Q91608358 P932 Q91608358-6D4A6974-B810-489B-8556-183356FE1B41 @default.
- Q91608358 P356 J.NEUROPHARM.2019.107690 @default.
- Q91608358 P698 31271770 @default.
- Q91608358 P1433 Q15332439 @default.
- Q91608358 P1476 "Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5" @default.
- Q91608358 P2093 "Catherine Harding-Rose" @default.
- Q91608358 P2093 "Donald A Simone" @default.
- Q91608358 P2093 "Eyup Akgün" @default.
- Q91608358 P2093 "Mary M Lunzer" @default.
- Q91608358 P2093 "Philip S Portoghese" @default.
- Q91608358 P2093 "Rebecca Speltz" @default.
- Q91608358 P2093 "Samuel J Erb" @default.
- Q91608358 P2093 "Sarah S Shueb" @default.
- Q91608358 P304 "107690" @default.
- Q91608358 P31 Q13442814 @default.
- Q91608358 P356 "10.1016/J.NEUROPHARM.2019.107690" @default.
- Q91608358 P478 "160" @default.
- Q91608358 P577 "2019-07-01T00:00:00Z" @default.
- Q91608358 P698 "31271770" @default.
- Q91608358 P921 Q18554919 @default.
- Q91608358 P921 Q3712728 @default.
- Q91608358 P932 "7210724" @default.